Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114735) titled 'In vitro radiation dosimetry study of 177Lu-PSMA in the treatment of metastatic prostate cancer' on Dec. 17, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai General Hospital
Condition:
Clinically or radiographically diagnosed metastatic prostate cancer
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2025-12-23
Target Sample Size: Observation group:6;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301162
Published by HT Digital Content Services with permission from He...